Curemark Garners $18,500,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=36993add-78c0-4218-b8b8-22216a16f33f
Date
10/10/2013
Company Name
Curemark
Mailing Address
411 Theodore Fremd Ave Rye, NY 10580
Company Description
Curemark is a socially driven biotechnology and development company whose focus is addressing the unmet health needs of individuals in the areas of neurology and gastrointestinal/pancreatic secretory deficiencies.
Website
http://www.curemark.com
Transaction Type
Venture Equity
Transaction Amount
$18,500,000
Transaction Round
Undisclosed
Proceeds Purposes
Curemark will use the funds for the completion and filing requirements for its New Drug Application (NDA) for CM-AT, the company’s autism treatment, and the development of the other therapies in its pipeline.
M&A Terms
Venture Investor
Undisclosed